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Abstract 
Objective: To determine the incidence of and risk factors for extrathoracic upper airway 
obstruction after pediatric cardiac surgery. 
Study Design: A retrospective chart review was performed on 213 patients less than 18 years 
of age who recovered from cardiac surgery in our multidisciplinary intensive care unit in 2012.  
Clinically significant upper airway obstruction was defined before performing the chart review as 
post-extubation stridor with at least one of the following: greater than two corticosteroid doses, 
receiving helium-oxygen therapy, or re-intubation.  Multivariate logistic regression analysis was 
performed to determine independent risk factors for this complication. 
Results:  Thirty-five patients (16%) with extrathoracic upper airway obstruction were identified. 
On bivariate analysis, patients with upper airway obstruction had greater surgical complexity, 
higher vasoactive medication requirements, and longer postoperative durations of endotracheal 
intubation.  They were also more difficult to calm while on mechanical ventilation, as indicated 
by higher narcotic infusion doses and greater likelihood to receive dexmedetomidine or 
vecuronium.   On multivariable analysis, adjunctive use of dexmedetomedine or vecuronium 
(odds ratio: 4.4, 95% confidence intervals: 1.8-10.5) remained independently associated with 
upper airway obstruction.  
Conclusion:  Extrathoracic upper airway obstruction is relatively common following pediatric 
cardiac surgery, especially in children who are difficult to calm while endotracheally intubated.  
Postoperative upper airway obstruction could represent an important outcome measure in future 
studies of optimal sedation practices in this patient population. 
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Introduction 
The outcomes of patients requiring pediatric cardiac surgery have steadily improved over the 
past quarter century.  Despite these improvements, postoperative management remains 
challenging in certain patients, especially in infants and children with complex cardiac defects or 
those who experience postoperative complications.  Extrathoracic upper airway obstruction is 
one such complication for which patients undergoing cardiac surgery are particularly at risk, 
resulting from either pre-existing underlying anatomic abnormalities, operative injury to the 
recurrent laryngeal nerve, or alterations to the airway associated with postoperative 
endotracheal intubation.1-5  Upper airway obstruction can lead to increased work of breathing, 
derangements in gas exchange, and increased transmural ventricular wall stress, all of which 
are poorly tolerated by a recovering myocardium.  Upper airway obstruction has also been 
implicated as important contributor to extubation failure, which has been associated with 
increased morbidity and mortality in this patient population.6-8  In the most severe cases, 
tracheostomy is required to facilitate long-term recovery.9-11  
  
Current literature cites wide-ranging incidences of upper airway obstruction in the non-cardiac 
pediatric ICU population from 5-40%.12-14  Despite the fact that it is also a well-recognized 
postoperative sequela in children undergoing cardiac surgery, data on characteristics of patients 
at risk for extrathoracic upper airway obstruction and the frequency with which it occurs within 
this patient population are limited.  We therefore aimed to determine the incidence of 
extrathoracic upper airway obstruction after pediatric cardiac surgery at our institution and 
identify risk factors for its occurrence.  Moreover, from our anecdotal observations, we 
hypothesized that agitated patients requiring considerable escalation of their analgesic and 
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sedative requirements would more commonly have post-extubation upper airway obstruction 
due to airway trauma from their endotracheal tube. 
  
Methods 
The Institutional Review Boards of the Detroit Medical Center and Wayne State University 
approved this retrospective study.  Children’s Hospital of Michigan is a 260-bed tertiary care 
hospital where two pediatric cardiovascular surgeons perform approximately 300-350 
operations per year on patients with congenital heart lesions in all of the complexity levels.  The 
cardiac surgical patients recover in our 26-bed PICU, where a multidisciplinary team provides 
care led by cardiovascular surgeons and pediatric intensive care physicians.  We reviewed all 
patients less than 18 years recovering from pediatric cardiothoracic surgery that arrived to our 
intensive care unit at our institution endotracheally intubated on mechanical ventilation between 
January 1, 2012 and December 31, 2012.  Patients with tracheostomy tubes in place prior to 
cardiac surgery, patients who underwent cardiac surgery and were admitted to the intensive 
care unit before January 1, 2012 but underwent their first extubation attempt from mechanical 
ventilation after this date, and patients who expired without any extubation attempt were 
excluded.  For patients who required multiple procedures during the calendar year, only hospital 
admission following the first procedure was reviewed. We reviewed 213 unique patients who 
met inclusion criteria, representing a wide variety of congenital heart defects (Table 1).  Of these 
patients, 54 (25%) were neonates at the time of surgery (<30 days old). 
  
Operative and Postoperative Management 
All children undergoing cardiac surgery on cardiopulmonary bypass received one dose of 
intravenous methylprednisolone 30 mg/kg prior to initiation of cardiopulmonary bypass.  All 
patients were admitted to the intensive care unit following cardiac surgery endotracheally 
intubated and were placed on synchronized intermittent mandatory ventilation.  Postoperative 
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management including titration of vasoactive medication to maintain hemodynamic stability, 
adjustments in intravenous fluid management to prevent electrolyte derangements, and 
administration of analgesia and sedation to treat postoperative pain and anxiety were at the 
discretion of the surgical and intensive care team.  For postoperative pain, most patients initially 
received intravenous morphine, either 0.05-0.1 mg/kg/dose intermittently or 10-20 mcg/kg/hour 
via continuous infusion.  In patients with considerable hemodynamic instability, intravenous 
fentanyl 1 mcg/kg/dose intermittently or 1-2 mcg/kg/hour as a continuous infusion was 
occasionally used as an alternative to morphine.  If patients continued to be agitated despite 
initiation and escalation of the dose of their narcotic infusion or if they exhibited excessive 
movement deemed hazardous to their postoperative stability, they then received either 
dexmedetomidine administered as a 1 mg/kg/dose bolus followed by continuous infusion at 0.2-
1 mcg/kg/hour, midazolam as a continuous infusion at 0.05-0.1 mg/kg/hour, intermittent 
neuromuscular blockade with vecuronium 0.1 mg/kg/dose, or a combination of these three 
regimens.  Continuous infusions of neuromuscular blockade are not used at our institution. 
  
Extubation from mechanical ventilator support was attempted based on extubation readiness 
guidelines that have been adopted as a standard of practice at our institution.  Specifically, 
extubation was attempted when patients were breathing comfortably with good gas exchange 
and without metabolic acidosis on the following settings: respiratory rate ≤ 5 breaths per minute, 
pressure support ≤ 10 cmH2O, positive end-expiratory pressure ≤ 5 cmH2O, and fraction of 
inspired oxygen concentration ≤ 0.4.  The decision as to whether or not to provide peri-
extubation corticosteroids as well as the timing of which this therapy was initiated was at the 
discretion of the ICU team.  For patients who were given peri-extubation corticosteroids, 
intravenous dexamethasone 0.5 mg/kg was administered every 6 hours, and the number of 
doses received prior to extubation was dependent on when the first dose was ordered.  Upon 
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extubation, patients were placed on oxygen via nasal cannula, the flow of which was also at the 
discretion of the ICU team. 
  
Data Collection and Definitions 
Preoperative data collected included age, gender, weight, weight-for age z-score (calculated 
based on Center for Disease Control / National Center for Health Statistics Weight-for-Age 
Percentiles, www.cdc.gov/growthcharts/zscore.htm), body surface area, history of prematurity 
(defined as less than 37 weeks gestation), presence of genetic abnormalities, preoperative 
cardiac diagnosis, preoperative surgical procedure, and  basic and comprehensive Aristotle 
scores.15  The Aristotle score is a risk stratification tool used to stratify pediatric cardiac surgical 
procedures based upon complexity.  Peri-operative data recorded included endotracheal tube 
size, number of intraoperative intubation attempts, duration of cardiopulmonary bypass, aortic 
cross clamp time, and deep hypothermic circulatory arrest time. Postoperative variables 
recorded included maximum positive end-expiratory pressure and positive inspiratory pressure 
provided via mechanical ventilation, inhaled nitric oxide use, number of doses of 
dexamethasone pre- and post-extubation from mechanical ventilation, duration of endotracheal 
intubation from the date of surgery to the first extubation attempt, presence of stridor post-
extubation, use of helium-oxygen therapy or racemic epinephrine post-extubation, and need for 
re-intubation.  Postoperative vasoactive inotrope requirements were quantitated by using the 
vasoactive-inotropic score (VIS) at 48 hours postoperatively, the postoperative time point at 
which the VIS has been shown to best correlate with postoperative outcomes.16  This score is 
calculated according to the following formula:  VIS = Dopamine (μg/kg/min) + dobutamine 
(μg/kg/min) + 100 X epinephrine (μg/kg/min) + 10 X milrinone (μg/kg/min) + 10,000 X 
vasopressin (U/kg/min) + 100 X norepinephrine (μg/kg/min).  We also recorded maximum dose 
of narcotic infusion in morphine equivalents, dexmedetomidine infusion, and midazolam 
infusions if implemented.  Fentanyl infusions were converted to morphine equivalents by 
 6 
multiplying the fentanyl dose by 80.17  We also recorded cumulative dose of vecuronium in 
patients in whom it was administered.  Lastly, we recorded outcome variables including 
postoperative duration of mechanical ventilation, intensive care unit length of stay, and mortality. 
   
Patients were defined, before performing the chart review, as having clinically significant 
extrathoracic upper airway obstruction if stridor was present and documentation of one or more 
of the following was noted in the medical record following their first extubation attempts: greater 
than two corticosteroid doses, need for helium-oxygen (heliox) therapy, or need for re-
intubation.  Patients without stridor who required re-intubation for other causes (e.g. 
cardiovascular insufficiency) were analyzed as part of the group of patients without clinically 
significant upper airway obstruction.  Patients in whom stridor resolved easily with racemic 
epinephrine alone were also not considered to have clinically significant upper airway 
obstruction.  Further, patients who received only 1-2 doses of post-extubation corticosteroids 
were receiving these doses as part of their 24-hour peri-extubation prophylaxis regimen typically 
employed at our institution, most often started at 12AM prior to extubation attempt planned for 
later that day - these patients were also not included as having clinically significant upper airway 
obstruction. Clinicians at our institution who employ dexamethasone to treat post-extubation 
upper airway obstruction provide in most cases at least 3-4 doses of post-extubation therapy.     
 
Statistical Analysis 
Data were represented as median (intraquartile range) or absolute count (percentage) unless 
otherwise noted.  Bivariate analysis was performed by comparing variables in those patients 
with upper airway obstruction to those without using Mann-Whitney U or χ-square tests as 
appropriate. Variables with P<0.1 on bivariate analysis were considered for inclusion in the 
multivariable analysis.  Multivariable logistic regression analysis was performed to determine 
independent risk factors for upper airway obstruction. Non-significant variables remained in the 
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model as potential confounders if odds ratios were appreciably altered (>5%) after backward 
elimination. 
  
 
Results 
Thirty-five patients (16%) developed clinically significant extrathoracic upper airway obstruction 
following extubation from mechanical ventilation.  Twenty-two additional patients were noted to 
have stridor that resolved quickly with nebulized racemic epinephrine administration. None of 
these patients were noted to have extrathoracic upper airway obstruction prior to surgery.    The 
use of post-extubation corticosteroids and helium-oxygen therapy to manage clinically 
significant postoperative upper airway obstruction, and the need for re-intubation secondary to 
upper airway obstruction are illustrated in Figure 1.  Of note, use of peri-extubation 
corticosteroids in an effort to prevent post-extubation upper airway obstruction was not 
statistically different in patients who ultimately developed clinically significant upper airway 
obstruction and those who did not, 43% vs 53%, respectively, P=0.42.   
  
Patient characteristics of those children with clinically significant upper airway obstruction 
following extubation from mechanical ventilation are further compared to those without upper 
airway obstruction in Table 2.  Patients with clinically significant upper airway obstruction were 
significantly more complex (greater Aristotle scores), required greater hemodynamic support 
postoperatively (greater 48-hour VIS), and were intubated significantly longer prior to their first 
extubation attempt as compared to patients without upper airway obstruction.  Patients with 
upper airway obstruction also received greater escalation of the dose of their narcotic infusion, 
and were significantly more likely to have received dexmedetomidine infusion or intermittent 
vecuronium.  Six patients in the study were endotracheally intubated in the neonatal intensive 
care unit prior to surgery, four of which remained endotracheally intubated on the day of 
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surgery.  None of these four patients developed clinically significant upper airway obstruction 
following extubation postoperatively.    
 
We also found that significantly smaller endotracheal tubes were placed in patients with upper 
airway obstruction, 4 mm (range: 3-5.5) versus 4 mm (range: 3-7), P=0.008.  This somewhat 
counterintuitive finding is likely explained by the trends observed toward smaller weight and 
body surface area in patients with upper airway obstruction.  Indeed, weight and endotracheal 
tube size were highly correlated (Spearman rho = 0.8793, P<0.001).  We therefore indexed 
endotracheal tube size to body surface area and found that there was a non-significant trend 
toward greater endotracheal tube size per m2 in patients with upper airway obstruction, 12.5 
mm/m2 (range: 5.9-20.6) versus 11.8 mm/m2 (range: 3.2-21.4), P=0.14.   
  
 The results of our multivariable analysis are provided in Table 3.  Our multivariable model 
included weight, presence of genetic abnormalities, Basic Aristotle Score, 48-hour vasoactive 
inotrope score, use of either dexmedetomidine or vecuronium as a dichotomous variable, and 
duration of mechanical ventilation.  Rather than include all variables related to postoperative 
analgesia, sedation, and neuromuscular blockade, in which there was frequent overlap, use of 
either dexmedetomidine or vecuronium (or both) as a dichotomous variable was chosen to more 
simply represent the need for a more aggressive pharmacologic means of quelling 
postoperative agitation or potentially harmful patient movement.  We also included endotracheal 
tube indexed to BSA in the model in order to be confident that our results were not confounded 
by this important variable.  Intraoperative deep hypothermic circulatory arrest, which 
approached statistical significance on bivariate analysis, had minimal effect on the model and 
was not included in the final analysis.     In our model, only adjunctive use of dexmedetomidine 
or vecuronium while endotracheally intubated was independently associated with postoperative 
upper airway obstruction (odds ratio: 3.4, 95% confidence intervals: 1.4-8.0).   In another model 
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that differed only from the previous model in that use of dexmedetomidine and use of 
vecuronium are in the model as two separate dichotomous variables, use of both of these 
agents remained independently associated with upper airway obstruction while the relationship 
between upper airway obstruction and the other six variables remained insignificant (data not 
shown). 
  
In regards to outcomes, patients with clinically significant extrathoracic upper airway obstruction 
had significant longer median total ICU length of stay [8.1 days (intraquartile range: 5.1-14.5) 
versus 4.2 days (intraquartile range: 2.5-9.3), P<0.001] and ICU length of stay following the 
initial extubation attempt [6.3 days (intraquartile range: 3.6-13.8) versus 3.2 days (intraquartile 
range: 1.8-6.5), P<0.001].  Flexible bronchoscopy was performed in 13 of the 35 patients with 
upper airway obstructions, which provided the following diagnoses:  vocal cord paralysis (n=5), 
subglottic stenosis (n=4), subglottic granulation tissue n=3), and airway mucositis (n=1).  Upper 
airway obstruction resolved in the other 22 patients without the need for further diagnostic 
procedures.  The etiology of the extrathoracic upper airway obstruction in the patients with vocal 
cord paralysis (i.e. damage to the recurrent laryngeal nerve) very likely differs from that of the 
other patients (e.g. airway trauma) in our study.  Hence, we repeated the multivariable 
regression analysis with the five patients with vocal cord paralysis excluded.  In this analysis, 
adjunctive use of dexmedetomidine or vecuronium while endotracheally intubated remained the 
only risk factor found to be independently associated with postoperative upper airway 
obstruction (odds ratio: 4.6, 95% confidence intervals. 1.8-11.8).  Lastly, only one patient in the 
study ultimately required tracheostomy (related to unilateral vocal cord paralysis), and of all 
patients in the study, there were two mortalities, neither of which could be attributed to post-
extubation upper airway obstruction. 
  
Discussion 
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In 1977, Battersby and colleagues, in an early study looking at postoperative respiratory 
complications following pediatric cardiac surgery, reported the incidence of postoperative stridor 
to be 4.8% in their patient population.1  Nearly forty years later, during which the field of 
pediatric cardiac surgery has undergone dramatic evolution, extrathoracic upper airway 
obstruction remains a well-recognized and potentially life-threatening postoperative 
complication.  Most studies of upper airway obstruction in this patient population since this early 
report however have focused on the more severe cases that lead to extubation failure or 
tracheostomy.   For example, upper airway obstruction leading to extubation failure has been 
implicated in 2-4% of patients in studies focused on children recovering from cardiac surgery.6-8  
Interestingly, one of these studies, 4 of 7 patients who failed extubation did so in the operating 
room secondary to extrathoracic upper airway obstruction,8 indicating, as also demonstrated in 
our report, that patients need not be endotracheally intubated for prolonged periods of time to 
experience post-extubation stridor.  In two studies of patients requiring tracheostomy following 
cardiac surgery, extrathoracic upper airway obstruction followed by tracheostomy placement 
occurred in 0.2% and 0.5% of patients.9-10  Vocal cord paralysis or subglottic stenosis as the 
cause of upper airway obstruction leading to tracheostomy accounted for most of these cases.  
Thus, though these studies focused on the most severe sequelae of extrathoracic upper airway 
obstruction have provided important and useful information, they have likely underestimated the 
incidence of this postoperative complication in this patient population.  
  
To our knowledge, our study is the first to date to focus exclusively on this postoperative 
extrathoracic upper airway obstruction in patients recovering from pediatric cardiac surgery, 
describe its incidence (16%), identify risk factors for its occurrence (marked agitation requiring 
escalation of pharmacologic analgesia, sedation, and neuromuscular blockade), and determine 
what percentage of the patients with UAO go on to develop extubation failure or tracheostomy 
(40% and 3%, respectively).  Our study has several implications.  Patients with postoperative 
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extrathoracic upper airway obstruction were found to have significantly longer intensive care unit 
stays than those patients without upper airway obstruction.  We acknowledge that the 
contribution of upper airway obstruction to these prolonged stays is unclear, considering these 
patients also required more complex surgical procedures and greater postoperative 
hemodynamic support.  Nevertheless, many of these patients received helium-oxygen therapy 
or were re-intubated, two interventions that undoubtedly increased the duration of intensive care 
management.  Perhaps more importantly, we hypothesized based on anecdotal observations 
that patients with considerable agitation postoperatively would be more likely to develop 
extrathoracic upper airway obstruction, and our results support this hypothesis. Patients who 
received dexmedetomidine or vecuronium, which are used at our institution as second or third-
line agents to manage postoperative sedation or quell potentially hazardous postoperative 
movements, had a four-fold greater adjusted odds of developing upper airway obstruction.  This 
finding likely reflects the cautious approach to postoperative analgesia and sedation that is 
standard at our institution, with the goal of preventing over-sedation and sparing patients 
excessive exposure to narcotics and sedatives.  This management style, while appropriate for 
many patients, can at times be associated with numerous periods of agitation and excessive 
movement as doses of narcotic infusions are carefully escalated and additional adjunctive 
agents are gradually implemented.  Patients receiving dexmedetomidine or vecuronium likely 
experienced these types of episodes more often, and the airway trauma resulting from these 
episodes seemed to have contributed more to the development of post-extubation upper airway 
obstruction than any other variables included in the study.  Intensive care unit regimens for 
narcotic and sedative administration vary widely across different institutions, and optimal 
practice is the subject of much debate among pediatric critical care physicians.17-18  We 
speculate that centers with a more aggressive initial approach to postoperative analgesia and 
sedation, or have lower thresholds for neuromuscular blockade, may have lower incidences of 
post-extubation upper airway obstruction (but also, possibly, higher incidences of over-
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sedation).  We therefore suggest that postoperative extrathoracic upper airway obstruction has 
potential as an outcome variable in future studies of optimal sedation practices in pediatric 
patients undergoing cardiac surgery.            
  
Incidentally, we found that prophylactic peri-extubation dexamethasone was not statistically 
different between children with and with clinically significant stridor in this study.  We 
acknowledge that the use of peri-extubation corticosteroids was not protocolized and 
interpretation of this result is therefore difficult.  We cannot discount the possibility that we would 
have found a higher rate of upper airway obstruction had this practice been less readily 
employed.  In light of our current findings, the conflicting nature of the data on dexamethasone 
use to prevent re-intubation in neonates and children,19 and more recent data linking peri-
operative and postoperative corticosteroid use in pediatric cardiac surgical patients to 
postoperative infection,20-21 further studies are needed before this practice can be readily 
promoted.  
  
Several limitations to our data should be noted. First, the retrospective nature of the study 
required us to define clinically significant extrathoracic upper airway obstruction based on the 
presence of stridor and documentation of one or more of our institutional practices indicative of 
treatment of a clinically significant upper airway obstruction.  We did however develop this 
definition before performing the chart review, with the aim of limiting the bias inherent to a 
retrospective review.  Secondly, we reiterate that our findings are that of a single center and 
may therefore not be generalizable to other centers, especially those with differing sedation 
practices.  At other centers, especially those with contrasting sedation practices, certain patient 
characteristics could prove to be important risk factors, such as weight and surgical complexity, 
which, in theory, could contribute to the development of upper airway obstruction.  Lastly, we 
also acknowledge that there could be other variables not considered in this report that could 
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have confounded our results.  Despite these limitations, our study provides useful data that 
describe upper airway obstruction as a relatively common and important cause of postoperative 
morbidity in children undergoing cardiac surgery, and its occurrence could potentially be 
tempered by limiting agitation while endotracheally intubated. 
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Table 1.  Primary Diagnoses and Surgeries Organized by Aristotle Complexity Level 
Aristotle Complexity Level Cardiac Lesion and Surgery N 
Level 1 
Complexity Basic Score 1.5-5.9 
N=17 (8.0%) 
Repair of atrial septal defect  
Repair of partial atrioventricular septal defect 
Other    
9 
3 
5 
Level 2 
Complexity Basic Score 6.0-7.9 
N=104 (48.8%) 
Repair of Ventricular septal defect 
Pulmonary artery-plasty 
Systemic-to-pulmonary shunt  
Aortic arch reconstruction  
Repair of subvalvar aortic stenosis 
Repair of right ventricular outflow tract obstruction 
Single ventricle – Hybrid procedure 
Tricuspid valvuloplasty 
Mitral valve replacement 
Repair of double chamber right ventricle 
Bidirectional cavopulmonary anastomosis  
Tetralogy of Fallot – non-transannular patch 
Other  
23 
14 
9 
8 
8 
7 
6 
6 
6 
5 
4 
4 
10 
Level 3  
Complexity Basic Score 8.0-9.9 
N=62 (29.1%) 
Repair of complete atrioventricular septal defect  
Tetralogy of Fallot - transannular patch 
Fontan Completion   
Mitral valvuloplasty / replacement 
Repair of total anomalous pulmonary venous return 
Revision of right ventricle-pulmonary artery conduit 
Complex aortic arch repair 
Other 
11 
9 
9 
6 
6 
6 
8 
7 
Level 4 
Complexity Basic Score 10-15 
N=30 (14.1%) 
 
D-transposition of great vessels - arterial switch  
Singe ventricle – Norwood procedure  
Repair of ventricular septal defect/aortic coarctation 
Repair of truncus arteriosus  
Other 
9 
6 
4 
2 
9 
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Table 2. Comparison of Patients With and Without Upper Airway Obstruction      
 
Variable UAO 
(N = 35) 
No UAO 
 (N = 178) 
P-value 
Age (months) 5 (0.7-14) 7.25 (1-55) 0.11 
Female 16 (46%) 83 (46%) 0.92 
Weight (kg) 5.6 (3.7-9.4) 6.5 (3.9-18) 0.07 
Body surface area (m2) 0.31 (0.22-0.43) 0.35 (0.23-0.73) 0.09 
Weight Z-Score −1.4 (−2.5,−0.3) −1 (−2.1,+0.2) 0.09 
Genetic syndrome 11 (31%) 31 (17%) 0.06 
Basic Aristotle Score 9 (6.3-10) 7.5 (6-8) 0.006 
Preoperative mechanical ventilation 1 (2.9%) 5 (2.8%) 0.66 
Intraoperative intubation attempts 1 (1-1) 1 (1-1) 0.94 
Cardiopulmonary bypass (minutes) 132 (70-201) 115 (64-172)  0.37 
Aortic cross-clamp (minutes) 70 (15-114) 55 (21-97)  0.51 
Deep hypothermic circulatory arrest 12 (34%)  37 (21%) 0.08 
Max PEEP (cm H2O)  5 (4-7)  5 (4-6) 0.38 
Max PIP (cm H2O) 24 (21-27)  24 (20-26) 0.64 
Inhaled nitric oxide use 9 (26%)  27 (15%) 0.13 
48-hour VIS 6 (0-10) 0 (0-7.5)  0.010 
Duration of ventilation (hours)    42 (20-95) 23 (9-48) 0.012 
Narcotic infusion use 24 (69%) 76 (43%) 0.005 
Maximum narcotic rate (mcg/kg/hour) a  20 (0-30)         0 (0-20) 0.022 
Dexmedetomidine infusion use 20 (57%) 46 (26%) < 0.001 
Maximum dexmedetomidine (mcg/kg/hour) 0.4 (0-0.6) 0 (0-0.2) <0.001 
Midazolam infusion use 5 (14%)  15 (8%) 0.28 
Maximum midazolam (mg/kg/hour) 0 (0-0) 0 (0-0) 0.26 
Vecuronium use 16 (45%) 26 (15%) < 0.001 
Cumulative vecuronium dose (mg/kg) 0 (0-1.5) 0 (0-0)  < 0.001 
Continuous variables represented as median (intraquartile range), categorical data represented as 
absolute counts (%); UAO: upper airway obstruction; PEEP: positive end-expiratory pressure; PIP: peak 
inspiratory pressure; VIS: vasoactive inotrope score; Statistical significance P <0.05 
a Morphine equivalents; for patients receiving fentanyl (N=17), fentanyl infusion rate was multiplied by 80 
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Table 3. Multivariable Logistic Regression Model for Upper Airway Obstruction 
 
Factors Odds Ratio 95% CI's P-value 
Weight 0.89  0.78-1.02   0.10 
Genetic Abnormalities 1.46  0.60-3.60   0.41 
Basic Aristotle Score 1.12   0.93-1.35    0.23 
Endotracheal tube size / BSA 0.89 0.73-1.08 0.26 
48-hour VIS 0.99   0.92-1.06 0.79 
Duration of Mechanical Ventilation 1.002  0.997-1.007   0.46 
Need for Dexmedetomidine or Vecuronium 3.38  1.43-7.96   0.005 
 VIS: vasoactive inotrope score; BSA: body surface area                                             
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Figure Legends 
 
Figure 1.  The number of patients who received greater than two doses of postoperative 
corticosteroids, helium oxygen therapy, or re-intubation to treat post-extubation extrathoracic 
upper airway obstruction.  Fourteen patients (40%) with upper airway obstruction ultimately 
failed extubation and required re-intubation.  
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